RXRX logo

RXRX Shareholders equity

annual shareholders equity:

$1.03B+$571.35M(+123.28%)
December 31, 2024

Summary

  • As of today (September 18, 2025), RXRX annual stockholders equity is $1.03 billion, with the most recent change of +$571.35 million (+123.28%) on December 31, 2024.
  • During the last 3 years, RXRX annual shareholders equity has risen by +$491.84 million (+90.59%).
  • RXRX annual shareholders equity is now at all-time high.

Performance

RXRX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXbalance sheet metrics

quarterly shareholders equity:

$919.15M-$14.80M(-1.58%)
June 30, 2025

Summary

  • As of today (September 18, 2025), RXRX quarterly stockholders equity is $919.15 million, with the most recent change of -$14.80 million (-1.58%) on June 30, 2025.
  • Over the past year, RXRX quarterly shareholders equity has increased by +$334.70 million (+57.27%).
  • RXRX quarterly shareholders equity is now -11.17% below its all-time high of $1.03 billion, reached on December 31, 2024.

Performance

RXRX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

RXRX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+123.3%+57.3%
3 y3 years+90.6%+110.0%
5 y5 years+1246.6%-

RXRX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+123.3%-11.2%+136.9%
5 y5-yearat high+1246.6%-11.2%+545.6%
alltimeall timeat high+1246.6%-11.2%+545.6%

RXRX Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$919.15M(-1.6%)
Mar 2025
-
$933.95M(-9.7%)
Dec 2024
$1.03B(+123.3%)
$1.03B(+97.3%)
Sep 2024
-
$524.56M(-10.2%)
Jun 2024
-
$584.45M(+45.7%)
Mar 2024
-
$401.15M(-13.4%)
Dec 2023
$463.44M(-4.6%)
$463.44M(+5.8%)
Sep 2023
-
$437.97M(-6.6%)
Jun 2023
-
$468.96M(+9.0%)
Mar 2023
-
$430.18M(-11.5%)
DateAnnualQuarterly
Dec 2022
$485.81M(-10.5%)
$485.81M(+25.2%)
Sep 2022
-
$388.03M(-11.3%)
Jun 2022
-
$437.58M(-11.3%)
Mar 2022
-
$493.57M(-9.1%)
Dec 2021
$542.94M(+124.3%)
$542.94M(-9.4%)
Sep 2021
-
$599.03M(-6.8%)
Jun 2021
-
$642.71M(+198.5%)
Mar 2021
-
$215.28M(-204.4%)
Dec 2020
$242.02M(+215.0%)
-
Dec 2020
-
-$206.29M
Dec 2019
$76.84M
-

FAQ

  • What is Recursion Pharmaceuticals, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
  • What is Recursion Pharmaceuticals, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

What is Recursion Pharmaceuticals, Inc. annual stockholders equity?

The current annual shareholders equity of RXRX is $1.03B

What is the all time high annual shareholders equity for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high annual stockholders equity is $1.03B

What is Recursion Pharmaceuticals, Inc. annual shareholders equity year-on-year change?

Over the past year, RXRX annual stockholders equity has changed by +$571.35M (+123.28%)

What is Recursion Pharmaceuticals, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of RXRX is $919.15M

What is the all time high quarterly shareholders equity for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $1.03B

What is Recursion Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

Over the past year, RXRX quarterly stockholders equity has changed by +$334.70M (+57.27%)
On this page